We are live on
!
Find out more
MU
Mirova US Portfolio holdings
AUM
$8.81B
1-Year Est. Return
21.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
–
AUM
$2.87B
AUM Growth
+$579M
(+25%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
16.24%
Top 10 Holdings %
Top 10 Hldgs %
69.51%
Holding
26
New
1
Increased
22
Reduced
3
Closed
–
Top Buys
| 1 |
Eli Lilly
LLY
|
+$89M |
| 2 |
NVIDIA
NVDA
|
+$62.7M |
| 3 |
Adobe
ADBE
|
+$51.4M |
| 4 |
Microsoft
MSFT
|
+$37.5M |
| 5 |
Mastercard
MA
|
+$34.1M |
Top Sells
| 1 |
SBNY
Signature Bank
SBNY
|
+$72.8M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$25.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$317K |
Sector Composition
| 1 | Technology | 30.13% |
| 2 | Healthcare | 18.27% |
| 3 | Financials | 17% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Materials | 7.73% |
Similar funds
MERSOM
CFB
MOACM
SWP
CB
WT
OAM
PEA
Mirova US's Q1 2021 Portfolio in Review
As of Q1 2021, Mirova US held 26 positions worth $2.87B, up 25% from $2.29B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Mirova US deployed $467M of net new capital in Q1 2021, opening 1 new position and adding to 22 existing holdings. Its largest new stake was Eli Lilly: 454,879 shares worth $85M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Signature Bank, an estimated $72.8M trimmed.
- Mirova US's largest Q1 2021 buy was Eli Lilly: 454,879 shares worth $85M.
- Mirova US added most to NVIDIA in Q1 2021, an estimated $62.7M increase.
- Mirova US's biggest Q1 2021 reduction was Signature Bank, cutting an estimated $72.8M.
- Mirova US's ten largest holdings make up 70% of its $2.87B portfolio in Q1 2021.
- Mirova US opened 1 new position and closed 0 in Q1 2021.
- Mirova US's portfolio value rose 25% quarter-over-quarter to $2.87B.
Based on Mirova US's 13F filing for Q1 2021, filed 17 May 2021.